Company news

Alkermes plc news in 2022

Alkermes plc's news releases, calls and decks from 2022, newest first.

View company

Alkermes to Present at the 41st Annual J.P. Morgan Healthcare Conference

December 27, 2022

Alkermes to Participate in the BofA Securities 2022 Biotech SMID Cap Conference

November 29, 2022

Alkermes to Participate in the 5th Annual Evercore ISI HealthCONx Conference

November 21, 2022

Alkermes to Participate in the Stifel Healthcare Conference

November 7, 2022

Alkermes Announces Recipients of 2022 Alkermes Inspiration Grants(R) Program

November 6, 2022

Alkermes Celebrates Hispanic Americans Who Are Trailblazers in the Mental Health Field

November 2, 2022

Alkermes plc Reports Third Quarter 2022 Financial Results

November 1, 2022

Alkermes plc Announces Intent to Separate Oncology Business

November 1, 2022

A Message on Corporate Responsibility From Richard F. Pops, Alkermes CEO

October 31, 2022

Alkermes Named Awardee of NEEBC's Best Practices Award 2021

October 27, 2022

Alkermes Announces Recipients of 2022 Alkermes Inspiration Grants® Program

October 26, 2022

Alkermes to Report Third Quarter Financial Results on Nov. 2, 2022

October 25, 2022

Alkermes Announces Launch of 5th Annual Alkermes Pathways Research Awards® Program

September 27, 2022

Alkermes Showcases Research from Psychiatry Portfolio at Psych Congress

September 19, 2022

Alkermes plc Reports Second Quarter 2022 Financial Results

July 26, 2022

Alkermes to Report Second Quarter Financial Results on July 27, 2022

July 19, 2022

Alkermes Announces Results of Annual General Meeting of Shareholders

July 6, 2022

Alkermes to Participate in the Goldman Sachs Healthcare Conference

June 7, 2022

Alkermes Announces 2022 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer

June 1, 2022

Alkermes to Participate in the Jefferies Healthcare Conference

May 31, 2022

Alkermes Presents ARTISTRY-1 Data at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

May 31, 2022

Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors

May 25, 2022

Alkermes Announces Four Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

May 8, 2022

Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month

May 1, 2022

Alkermes plc Reports First Quarter 2022 Financial Results

April 26, 2022

Alkermes to Report First Quarter Financial Results on April 27, 2022

April 19, 2022

Alkermes Commences Arbitration Related to License Agreements with Janssen Pharmaceutica

April 18, 2022

Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society

April 6, 2022

Alkermes to Participate in the Stifel 2022 CNS Days

March 21, 2022

Alkermes to Present Data on Nemvaleukin Alfa at the Society of Gynecologic Oncology 2022 Annual Meeting on Women's Cancer

February 28, 2022

Alkermes Presents New Nemvaleukin Alfa Monotherapy Data at the American Society of Clinical Oncology Genitourinary Cancers Symposium

February 16, 2022

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2021 and Provides Financial Expectations for 2022

February 15, 2022

Alkermes Announces Positive Topline Results From ENLIGHTEN-Early Phase 3b Study of LYBALVI® in Patients Early in Illness

February 7, 2022

Alkermes to Report Fourth Quarter and Year-End 2021 Financial Results on Feb. 16, 2022

February 1, 2022

Alkermes to Present Data on Nemvaleukin Alfa at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium

January 17, 2022

Alkermes to Take Part in the 40th Annual J.P. Morgan Healthcare Conference

January 4, 2022

Calls in 2022

Decks in 2022